112 related articles for article (PubMed ID: 9453347)
1. Impact of dietary Na+ on glycyrrhetinic acid-like factors (kidney 11beta-(HSD2)-GALFs) in human essential hypertension.
Morris DJ; Lo YH; Lichtfield WR; Williams GH
Hypertension; 1998 Jan; 31(1 Pt 2):469-72. PubMed ID: 9453347
[TBL] [Abstract][Full Text] [Related]
2. Kidney 11 beta-HSD2 is inhibited by glycyrrhetinic acid-like factors in human urine.
Lo YH; Sheff MF; Latif SA; Ribeiro C; Silver H; Brem AS; Morris DJ
Hypertension; 1997 Jan; 29(1 Pt 2):500-5. PubMed ID: 9039149
[TBL] [Abstract][Full Text] [Related]
3. Correlation of glycyrrhetinic acid-like factors (kidney 11beta-HSD2-GALFs) with urinary free cortisol and plasma renin activity in essential hypertension.
Morris DJ; Latif SA; Lo YH; Abrampah K; Brem AS; Lichtfield WR; Williams GH
J Am Soc Hypertens; 2008; 2(4):286-93. PubMed ID: 20409908
[TBL] [Abstract][Full Text] [Related]
4. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
Morris DJ; Latif SA; Hardy MP; Brem AS
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
[TBL] [Abstract][Full Text] [Related]
5. Endogenous renal 11 beta-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension.
Takeda Y; Miyamori I; Iki K; Inaba S; Furukawa K; Hatakeyama H; Yoneda T; Takeda R
Hypertension; 1996 Feb; 27(2):197-201. PubMed ID: 8567041
[TBL] [Abstract][Full Text] [Related]
6. Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesis.
Morris DJ; Brem AS; Odermatt A
J Steroid Biochem Mol Biol; 2021 Nov; 214():105988. PubMed ID: 34464733
[TBL] [Abstract][Full Text] [Related]
7. An alternative explanation of hypertension associated with 17α-hydroxylase deficiency syndrome.
Morris DJ; Latif SA; Brem AS
Steroids; 2014 Jan; 79():44-8. PubMed ID: 24176792
[TBL] [Abstract][Full Text] [Related]
8. Detection of glycyrrhetinic acid-like factors (GALFs) in human urine.
Morris DJ; Semafuko WE; Latif SA; Vogel B; Grimes CA; Sheff MF
Hypertension; 1992 Sep; 20(3):356-60. PubMed ID: 1516955
[TBL] [Abstract][Full Text] [Related]
9. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
Ricketts ML; Stewart PM
Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
[TBL] [Abstract][Full Text] [Related]
10. 3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11β-hydroxysteroid dehydrogenase 2.
Makino T; Okajima K; Uebayashi R; Ohtake N; Inoue K; Mizukami H
J Pharmacol Exp Ther; 2012 Aug; 342(2):297-304. PubMed ID: 22543032
[TBL] [Abstract][Full Text] [Related]
11. Endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase in hypertension.
Walker BR; Aggarwal I; Stewart PM; Padfield PL; Edwards CR
J Clin Endocrinol Metab; 1995 Feb; 80(2):529-33. PubMed ID: 7852515
[TBL] [Abstract][Full Text] [Related]
12. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo.
Best R; Walker BR
Clin Endocrinol (Oxf); 1997 Aug; 47(2):231-6. PubMed ID: 9302399
[TBL] [Abstract][Full Text] [Related]
13. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension.
Hatakeyama H; Inaba S; Miyamori I
Hypertension; 1999 May; 33(5):1179-84. PubMed ID: 10334808
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandins and leukotriene B4 are potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 2 activity in human choriocarcinoma JEG-3 cells.
Hardy DB; Pereria LE; Yang K
Biol Reprod; 1999 Jul; 61(1):40-5. PubMed ID: 10377029
[TBL] [Abstract][Full Text] [Related]
16. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
[TBL] [Abstract][Full Text] [Related]
17. Renal 11beta-hydroxysteroid dehydrogenase in genetically salt-sensitive hypertensive rats.
Takeda Y; Inaba S; Furukawa K; Miyamori I
Hypertension; 1998 Dec; 32(6):1077-82. PubMed ID: 9856977
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension.
Brand E; Kato N; Chatelain N; Krozowski ZS; Jeunemaitre X; Corvol P; Plouin PF; Cambien F; Pascoe L; Soubrier F
J Hypertens; 1998 Nov; 16(11):1627-33. PubMed ID: 9856363
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of sheep kidney 11 beta-hydroxysteroid dehydrogenase isoform 2 activity by 5 alpha-reduced (but not 5 beta) derivatives of adrenocorticosteroids.
Latif SA; Sheff MF; Ribeiro CE; Morris DJ
Steroids; 1997 Feb; 62(2):230-7. PubMed ID: 9055382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
